ITGA4 and COVID-19: We compared patients with severe or critical illness, not only revealing shared features relating to emergency myelopoiesis and progenitors but also identifying discriminating neutrophil markers (CD49d:CD43 ratio) in COVID-19 (summarized in graphical abstract).